Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial

Respiratory Medicine

Volumn 106, Issue 5, 2012, Pages 642-650

  Bateman, Eric D ^a   Bleecker, Eugene R ^b   Lötvall, Jan ^c   Woodcock, Ashley ^d   Forth, Richard ^e   Medley, Hilary ^f   Davis, Angela M ^e   Jacques, Loretta ^f   Haumann, Brett ^f   Busse, William W ^g  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e GLAXOSMITHKLINE   (United States)

^f GLAXOSMITHKLINE   (United Kingdom)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Asthma; Dose response; Evening dosing; Fluticasone furoate; Inhaled corticosteroids; Once daily dosing

Indexed keywords

FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; PLACEBO; SALBUTAMOL;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; MULTICENTER STUDY; OROPHARYNGEAL PAIN; OROPHARYNX CANDIDIASIS; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCHOOL CHILD; SINUSITIS; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859110112     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.01.004     Document Type: Article

References (34)

1. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention 2009 http://www.ginasthma.com/ Date last updated: December 2010, [accessed 28.09.11]
2. National Institutes of Health Guidelines for the diagnosis and management of asthma (EPR-3) 2007 August; 2007 NHLBI NIH publication no. 08-4051
3. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. http://www.brit-thoracic.org.uk/guidelines/asthma-guidelines.aspx. Date last updated: May 2011, [accessed 28.09.11].
4. S. Pedersen, and P. O'Byrne A comparison of efficacy and safety of inhaled corticosteroids in asthma Allergy 52 1997 1 34
5. R.A. Pauwels, C.G. Löfdahl, and D.S. Postma Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteroids Establishing therapy (FACET) International Study Group N Engl J Med 337 1997 1405 1411
6. S. Suissa, P. Ernst, and S. Benayoun Low-dose inhaled corticosteroids and the prevention of death from asthma N Engl J Med 343 2000 332 336
7. C. Jones, N.C. Santanello, and S.J. Boccuzzi Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data J Asthma 40 2003 93 101
8. M. Axelsson, M. Emilsson, and E. Brink Personality, adherence, asthma control and health-related quality of life in young adult asthmatics Respir Med 103 2009 1033 1040
9. S.W. Stoloff, D.A. Stempel, and J. Meyer Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies J Allergy Clin Immunol 113 2004 245 251
10. G.M. Cochrane, R. Horne, and P. Chanez Compliance in asthma Respir Med 93 1999 763 769
11. D. Price, A. Robertson, and K. Bullen Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study BMC Pulm Med 10 2010 1
12. D.S. Postma, C. Sevette, and Y. Martinat Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening Eur Respir J 17 2001 1083 1088
13. A.H. Jones, C.G. Langdon, and P.S. Lee Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma Respir Med 88 1994 293 299
14. M. Noonan, J.P. Karpel, and G.W. Bensch Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler Ann Allergy Asthma Immunol 86 2001 36 43
15. W.W. Busse, P. Chervinsky, and J. Condemi Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma J Allergy Clin Immunol 101 1998 457 463
16. M. Masoli, M. Weatherall, S. Holt, and R. Beasley Clinical dose-response relationship of fluticasone propionate in adults with asthma Thorax 59 2004 16 20
17. N.P. Adams, and P.W. Jones The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews Respir Med 100 2006 1297 1306
18. M. Salter, K. Biggadike, and J.L. Matthews Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease Am J Physiol Lung Cell Mol Physiol 293 2007 L660 L667
19. K. Biggadike, R.K. Bledsoe, and A.M. Hassell X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain J Med Chem 51 2008 3349 3352
20. M. van den Berge, B. Luijk, and P. Bareille Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma Allergy 65 2010 1531 1535
21. E.R. Bleecker, E.D. Bateman, and W. Busse Fluticasone furoate (FF), an inhaled corticosteroid (ICS), is efficacious in asthma patients symptomatic on low doses of ICS therapy Eur Respir J 36 Suppl. 54 2010 204s
22. W. Busse, E.R. Bleecker, and E.D. Bateman Fluticasone furoate demonstrates efficacy in asthma patients symptomatic on medium doses of inhaled corticosteroid therapy: a randomised, placebo-controlled trial Thorax 67 2012 35 41
23. A. Woodcock, E.D. Bateman, and W.W. Busse Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma Resp Res 12 2011 160
24. M. Cazzola, and M.G. Matera Emerging inhaled bronchodilators: an update Eur Respir J 34 2009 757 769
25. E.D. Bateman, E.R. Bleecker, and W. Busse Fluticasone furoate (FF), a once-daily inhaled corticosteroid (ICS), demonstrates dose-response efficacy in patients symptomatic on non-steroidal asthma therapy Eur Respir J 36 Suppl. 54 2010 204s
26. D. Ukena, C. Biberger, V. Steinijans, V. von Behren, R. Malek, H.H. Weber, E. Beck, and A. Linnhoff Ciclesonide is more effective than budesonide in the treatment of persistent asthma Pulm Pharmacol Ther 20 2007 562 570
27. D.S. Postma, P.M. O'Byrne, and S. Pedersen Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control Chest 139 2011 311 318
28. G.K. Fritz, S.K. Adams, E.L. McQuaid, R. Klein, S. Kopel, J. Nassau, and A. Mansell Symptom perception in pediatric asthma: resistive loading and in vivo assessment compared Chest 132 2007 884 889
29. M.R. Miller, J. Hankinson, and V. Brusasco Standardisation of spirometry Eur Respir J 26 2005 319 338
30. N.P. Adams, J.C. Bestall, and T.J. Lasserson Fluticasone versus placebo for chronic asthma in adults and children Cochrane Database Syst Rev 4 2008 CD003135
31. M.E. Purucker, C.J. Rosebraugh, and F. Jhou Inhaled fluticasone proprionate by Diskus in the treatment of asthma Chest 124 2003 1584 1593
32. S. Accordini, M. Bugiani, and W. Arossa Poor control increases the economic cost of asthma. A multicentre population-based study Int Arch Allergy Immunol 141 2006 189 198
33. J.P. Karpel, and H. Nelson Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma Curr Med Res Opin 23 2007 2897 2911
34. A. Woodcock, E.R. Bleecker, and E.D. Bateman Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial Respir Res 12 2011 132